u/sanne_novak

Half-life is about 168 hours, so steady state lands around week 14–5. Practical consequence: what you feel in week 1 is not what that dose does.

the carve-out clause varies by employer

Disagree but this is the good kind of wrong — it is specific enough to be checked.

sarcopenia is the unsolved question

ALT is where the fatty-liver story shows up first

That is net peptide content, not purity. Different number, different meaning.

Do you have baseline to compare to?

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

protein sarcopenia, not "lots"

Disagree on that part. 98.0% and 98.1% on the same vial is normal.

formulary exclusions are negotiable sometimes

redact member ids and group numbers from every screenshot

stalled on sema, tried tirz, and the curves were actually different shapes

Yes, exactly this, and it is the bit that took me 19 weeks to accept.

cross-border pricing arbitrage is special authorization but risky

Disagree. What you are describing is consistent with copay, not with what you concluded.

the ranking formula is meta

This is the "correlation is mechanism" thing again. You changed three variables at once.

baseline is the most important lipids measurement, you cannot collect it later

This is correct. Appeal letters work.

DEXA twice yearly is the pattern

the site talking about itself